Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement
NCT: NCT06020508 · RECRUITING
Brief Summary
The goal of this clinical trial is to test the BrightPoint Epidural device as the first system to use multispectral reflectometry to find the epidural space in lumbar neuraxial procedures requiring epidural needle. The main questions it aims to answer are: 1. Is the device a qualitatively effective secondary confirmation of Loss of Resistance? 2. Is the device a qualitatively effective training tool for educating trainees in how to perform lumbar epidurals? Participants will undergo a neuraxial procedure in which the attending anesthesiologist will use the BrightPoint epidural device to form an opinion on its effectiveness in confirming epidural space access.
Frequently Asked Questions
What is Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement?
Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement is a clinical trial registered under NCT06020508. Current status: RECRUITING.
What is the status of NCT06020508?
The current status of NCT06020508 (Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement) is: RECRUITING.
When did Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement start?
Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement started on 2023-09-12.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.